0 items USD 0.00Search
Your search for "globaldata new zealand pharmaceuticals ltd pharmaceuticals healthcare deals alliances profile" gave back 46124 results.
The global Procarbazine market size is expected to reach $ 2874.9 million by 2029, rising at a market growth of 3.5% CAGR during the forecast period...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Perfluorocarbon PFC is a straight-chain or cyclic hydrocarbon fluorine substitution, at room temperature and pressure can dissolve a large number of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Congenital hyperinsulinism (CHI) is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Procarbazine market size is projected to grow from US$ 2142.4 million in 2022 to US$ 2788.7 million in 2029; it is expected to grow at a...
Catalog:
LPI
April 2023
Price: USD 3,660.00
The global Procarbazine market size was valued at USD 2253.4 million in 2022 and is forecast to a readjusted size of USD 2874.9 million by 2029 with...
Catalog:
GIR
May 2023
Price: USD 3,480.00
The global Severe Hypoglycemia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Congenital hyperinsulinism (CHI) is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Congenital hyperinsulinism (CHI) is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps...
Catalog:
GIR
February 2023
Price: USD 3,480.00
According to our Publisher latest study, the global Severe Hypoglycemia Treatment market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Severe Hypoglycemia Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of %...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Congenital hyperinsulinism (CHI) is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Publisher' newest research report, the “Severe Hypoglycemia Treatment Industry Forecast” looks at past sales and reviews total world Severe...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Ischemia Reperfusion Injury Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
